Information Provided By:
Fly News Breaks for February 7, 2020
Feb 7, 2020 | 07:40 EDT
JPMorgan analyst Tycho Peterson lowered his price target for Myriad Genetics to $17 from $20 saying the company last night reported "yet another disappointing miss" and significant fiscal 2020 guidance cut. He believes a number of key questions on execution remain unaddressed and keeps an Underweight rating on the shares.
News For MYGN From the Last 2 Days
There are no results for your query MYGN